NOT-NS-19-017: Notice to update Application Types Allowed for PAR-18-763 "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33)

Notice to update Application Types Allowed for PAR-18-763 "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33)

Notice Number: NOT-NS-19-017

Key Dates
Release Date: December 19, 2018

Related Announcements
PAR-18-763

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to update the Application Types Allowed for PAR-18-763 "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) ". Specifically, NINDS will accept resubmission applications in response to this Funding Opportunity Announcement (FOA) from PAR-18-763 and RFA-NS-16-013.

Section II. Award Information

Application Types Allowed

Currently Reads:

New
Resubmission
Revision
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Modified to Read:

New
Resubmission (PAR-18-763 or RFA-NS-16-013)
Revision
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Rebecca Roof, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]